Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSLPE.L Regulatory News (SLPE)

  • There is currently no data for SLPE

Quarterly Trading Statement

20 Sep 2017 07:00

RNS Number : 1924R
Standard Life Private Eqty Trst PLC
20 September 2017
 

Standard Life Private Equity Trust PLC

 

1. Investment update for the quarter ended 30 June 2017

 

· The Company's net asset value ("NAV") per ordinary share increased by 5.9% to 390.6 pence for the quarter ended 30 June 2017

· Realised gains and income during the quarter ended 30 June 2017 were £16.0 million (2.8% of NAV). The unrealised gains on the portfolio on a constant exchange rate basis were £10.0 million (1.8% of NAV); in addition, there were unrealised foreign exchange gains of £8.3 million (1.5% of NAV)

· 93.2% by value of the portfolio was valued by the respective underlying managers at 30 June 2017

· NAV total return was 13.7% for the nine months from 1 October 2016 to 30 June 2017.

· Outstanding commitments were £331.2 million at 30 June 2017

· Liquid resources were £111.6 million at 30 June 2017

 

For the quarter ended 30 June 2017 the Company's NAV increased by 5.9% to 390.6 pence per share, from 368.9 pence per share at 31 March 2017. At 30 June 2017 the Company's net assets were £600.5 million (31 March 2017 - £567.2 million). NAV total return was 13.7% for the nine months from 1 October 2016 to 30 June 2017.

 

The closing value of the Company's portfolio, which, included 50 private equity fund interests, was £488.2 million at 30 June 2017 (31 March 2017 - £470.2 million and 49 private equity fund interests). The total unrealised gains on the portfolio for the quarter ended 30 June 2017 were £18.3 million, comprising £10.0 million of unrealised gains on a constant exchange rate basis and £8.3 million of unrealised foreign exchange gains. The MSCI Europe Index (in sterling) and the FTSE All Share Index (in sterling) rose by 3.7% and 1.4% respectively during the quarter. The unrealised foreign exchange gains were driven by the euro appreciating by 2.6% relative to sterling over the quarter, offset by the US dollar depreciating 3.9% relative to sterling.

 

During the quarter ended 30 June 2017 the Company received £32.1 million of distributions (six months ended 31 March 2017 - £73.5 million) and funded £13.2 million of drawdowns (six months ended 31 March 2017 - £46.1 million). The distributions received during the quarter generated £16.0 million of net realised gains and income, which was equivalent to a return of 2.1 times the acquisition cost of the realised investments. Total distributions and drawdowns for the nine months ended 30 June 2017 were £105.6 million and £59.3 million, respectively.

 

The Company made one new fund commitment of €35.0 million to CVC Capital Partners VII. The Company had total outstanding commitments to its 50 private equity fund interests of £331.2 million at 30 June 2017 (31 March 2017 - £312.2 million and 49 private equity fund interests). The Manager continues to believe that around £60 million of the Company's existing outstanding commitments are unlikely to be drawn.

 

At 30 June 2017 the Company had liquid resources of £111.6 million comprised of cash and cash equivalents (31 March 2017 - liquid resources of £97.7 million). The Company continues to have an undrawn £80 million syndicated revolving credit facility provided by Citibank and Societe Generale that expires in December 2020.

2. Activity since 30 June 2017

 

On 21 July 2017 the Company paid an interim dividend for the year ended 30 September 2017 of 6.0 pence per ordinary share. The cost of the interim dividend was £9.2 million.

 

During the period from 1 July to 8 September 2017 the Company funded £24.0 million of drawdowns and received £21.1 million of distributions.

 

A new commitment of €30.0 million was made to Nordic Capital Fund IX on 29 August. At 8 September 2017 the Company had liquid resources of £101.9 million. The Company also had total outstanding commitments of £344.9 million.

 

The Company's estimated NAV at 31 August 2017 is also being announced today. It is anticipated that the Company will release its preliminary announcement for the financial year ending 30 September 2017 on or around 4 December 2017.

 

 

For further information please contact:-

 

Roger Pim at SL Capital Partners LLP (0131 245 0055)

 

Note:-

Standard Life Private Equity Trust PLC is an investment company managed by SL Capital Partners LLP, the ordinary shares of which are admitted to listing by the UK Listing Authority and to trading on the Stock Exchange and which seeks to conduct its affairs so as to qualify as an investment trust under sections 1158-1165 of the Corporation Tax Act 2010. The Board of Standard Life Private Equity Trust PLC is independent of Standard Life Aberdeen plc.

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTXKLFFDKFXBBQ
Date   Source Headline
1st Jul 200911:19 amRNSTotal Voting Rights
30th Jun 20093:31 pmRNSDirector/PDMR Shareholding
26th Jun 20099:00 amRNSIssue of Equity
9th Jun 200912:17 pmRNSDirector/PDMR Shareholding
3rd Jun 20092:22 pmRNSDirector/PDMR Shareholding
2nd Jun 200910:20 amRNSDirector/PDMR Shareholding
29th May 20097:00 amRNSHalf Yearly Report
24th Mar 20097:30 amRNSTrading Statement
24th Feb 200910:15 amRNSSecondary Sales
3rd Feb 20092:37 pmRNSHolding(s) in Company
2nd Feb 200912:37 pmRNSDirector/PDMR Shareholding
2nd Feb 200912:34 pmRNSDirector/PDMR Shareholding
2nd Feb 200912:30 pmRNSTotal Voting Rights
2nd Feb 200911:23 amRNSHolding(s) in Company
27th Jan 200910:10 amRNSIssue of Shares following Scrip Dividend
26th Jan 20094:20 pmRNSInterim Management Statement
26th Jan 20094:08 pmRNSResult of AGM
26th Jan 200912:19 pmRNSDirectorate Change
14th Jan 20097:00 amRNSDisposal of Private Equity Fund Interests
8th Jan 20093:00 pmRNSScrip Dividend reference price
5th Jan 20094:05 pmRNSAnnual Financial Report
5th Jan 20094:00 pmRNSAnnual Information Update
18th Dec 20084:00 pmRNSAppointment of Broker
18th Dec 200811:46 amRNSDirector/PDMR Shareholding
17th Dec 20082:43 pmRNSDoc re. Annual Report
4th Dec 20084:49 pmRNSDirector/PDMR Shareholding
1st Dec 20087:00 amRNSFinal Results
27th Nov 20082:21 pmRNSDirectorate Change
23rd Sep 20087:00 amRNS3rd Quarter Trading Statement
22nd Sep 20082:37 pmRNSResult of EGM
22nd Aug 20087:00 amRNSCircular re EGM
30th Jul 20084:42 pmRNSSecond Price Monitoring Extn
30th Jul 20084:36 pmRNSPrice Monitoring Extension
24th Jul 20087:30 amRNSInterim Management Statement
15th Jul 20084:37 pmRNSDirector/PDMR Shareholding
30th Jun 200810:16 amRNSDirector Declaration
17th Jun 20084:22 pmRNSDoc re. Interim Report
30th May 20087:00 amRNSInterim Results
20th May 20083:18 pmRNSHolding(s) in Company
18th Mar 20082:58 pmRNSDirector/PDMR Shareholding
18th Mar 20087:00 amRNSTrading Statement
30th Jan 200810:31 amRNSDirector/PDMR Shareholding
29th Jan 20089:00 amRNSInterim Management Statement
28th Jan 20084:20 pmRNSResult of AGM
10th Jan 200810:31 amRNSAnnual Information Update
3rd Jan 200810:23 amRNSPortfolio Update
3rd Jan 200810:21 amRNSTotal Voting Rights
27th Dec 200710:33 amRNSDirector/PDMR Shareholding
20th Dec 20072:00 pmRNSDoc re. Annual Report
28th Nov 20077:00 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.